These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

568 related articles for article (PubMed ID: 25924179)

  • 21. The syndrome of inappropriate antidiuretic hormone: current and future management options.
    Sherlock M; Thompson CJ
    Eur J Endocrinol; 2010 Jun; 162 Suppl 1():S13-8. PubMed ID: 20164215
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vasopressin receptor antagonist in the treatment of the syndrome of inappropriate antidiuretic hormone in general hospital practice.
    Rajendran R; Grossman AB; Kar P
    Endocr J; 2012; 59(10):903-9. PubMed ID: 22785335
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aetiological diagnosis of hyponatraemia in non-critical patients on total parenteral nutrition: A prospective multicentre study.
    Ortolá Buigues A; Gómez-Hoyos E; Ballesteros Pomar MD; Vidal Casariego A; García Delgado Y; Ocón Bretón MJ; Abad González ÁL; Luengo Pérez LM; Matía Martín P; Tapia Guerrero MJ; Del Olmo García MD; Herrero Ruiz A; Álvarez Hernández J; Tejera Pérez C; Herranz Antolín S; Tenorio Jiménez C; García Zafra MV; Botella Romero F; Argente Pla M; Martínez Olmos MÁ; Bretón Lemes I; Runkle De la Vega I; De Luis Román D
    Endocrinol Diabetes Nutr (Engl Ed); 2022 Mar; 69(3):160-167. PubMed ID: 35396114
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tolvaptan Treatment in Children with Chronic Hyponatremia due to Inappropriate Antidiuretic Hormone Secretion: A Report of Three Cases.
    Tuli G; Tessaris D; Einaudi S; De Sanctis L; Matarazzo P
    J Clin Res Pediatr Endocrinol; 2017 Sep; 9(3):288-292. PubMed ID: 28515029
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of hypervolemic or euvolemic hyponatremia associated with heart failure, cirrhosis, or the syndrome of inappropriate antidiuretic hormone with tolvaptan: a clinical review.
    Nemerovski C; Hutchinson DJ
    Clin Ther; 2010 Jun; 32(6):1015-32. PubMed ID: 20637957
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tolvaptan for the treatment of hyponatremia secondary to the syndrome of inappropriate antidiuretic hormone secretion.
    Gargani L; Schmidt PH; Gheorghiade M
    Expert Rev Cardiovasc Ther; 2011 Dec; 9(12):1505-13. PubMed ID: 22103869
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hyponatremia, arginine vasopressin dysregulation, and vasopressin receptor antagonism.
    Rai A; Whaley-Connell A; McFarlane S; Sowers JR
    Am J Nephrol; 2006; 26(6):579-89. PubMed ID: 17170524
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A vasopressin receptor antagonist (VPA-985) improves serum sodium concentration in patients with hyponatremia: a multicenter, randomized, placebo-controlled trial.
    Wong F; Blei AT; Blendis LM; Thuluvath PJ
    Hepatology; 2003 Jan; 37(1):182-91. PubMed ID: 12500203
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potential roles of vaptans in heart failure: experience from clinical trials and considerations for optimizing therapy in target patients.
    Lin TE; Adams KF; Patterson JH
    Heart Fail Clin; 2014 Oct; 10(4):607-20. PubMed ID: 25217436
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intravenous conivaptan for the treatment of hyponatraemia caused by the syndrome of inappropriate secretion of antidiuretic hormone in hospitalized patients: a single-centre experience.
    Velez JC; Dopson SJ; Sanders DS; Delay TA; Arthur JM
    Nephrol Dial Transplant; 2010 May; 25(5):1524-31. PubMed ID: 20064953
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Therapy with vasopressin receptor antagonists: the aquaretics].
    Buemi M; Bolignano D; Coppolino G; Sturiale A; Campo S; Crasci' E; Aloisi C; Frisina N
    G Ital Nefrol; 2007; 24(5):371-80. PubMed ID: 17886207
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Meta-analysis: the safety and efficacy of vaptans (tolvaptan, satavaptan and lixivaptan) in cirrhosis with ascites or hyponatraemia.
    Dahl E; Gluud LL; Kimer N; Krag A
    Aliment Pharmacol Ther; 2012 Oct; 36(7):619-26. PubMed ID: 22908905
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hyponatremia in cirrhosis: pathophysiology and management.
    John S; Thuluvath PJ
    World J Gastroenterol; 2015 Mar; 21(11):3197-205. PubMed ID: 25805925
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management of euvolemic hyponatremia attributed to SIADH in the hospital setting.
    Peri A; Giuliani C
    Minerva Endocrinol; 2014 Mar; 39(1):33-41. PubMed ID: 24513602
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of hyponatremia: the role of lixivaptan.
    Liamis G; Filippatos TD; Elisaf MS
    Expert Rev Clin Pharmacol; 2014 Jul; 7(4):431-41. PubMed ID: 24766294
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Electrolytes: Sodium Disorders.
    Braun MM; Mahowald M
    FP Essent; 2017 Aug; 459():11-20. PubMed ID: 28806046
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnosis and management of hyponatraemia in the older patient.
    Woodward M; Gonski P; Grossmann M; Obeid J; Scholes R; Topliss DJ
    Intern Med J; 2018 Jan; 48 Suppl 1():5-12. PubMed ID: 29318728
    [TBL] [Abstract][Full Text] [Related]  

  • 38. AVP receptor antagonists as aquaretics: review and assessment of clinical data.
    Verbalis JG
    Cleve Clin J Med; 2006 Sep; 73 Suppl 3():S24-33. PubMed ID: 16970150
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vasopressin V2 receptor antagonists.
    Wong LL; Verbalis JG
    Cardiovasc Res; 2001 Aug; 51(3):391-402. PubMed ID: 11476729
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost-effectiveness of tolvaptan for the treatment of hyponatraemia secondary to syndrome of inappropriate antidiuretic hormone secretion in Sweden.
    Jamookeeah C; Robinson P; O'Reilly K; Lundberg J; Gisby M; Ländin M; Skov J; Trueman D
    BMC Endocr Disord; 2016 May; 16(1):22. PubMed ID: 27184496
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.